The synthetic vasopressin analogue is an injectable medication indicated for patients with hepatorenal syndrome who are experiencing rapid deterioration of kidney function (type 1 hepatorenal syndrome).
DaxibotulinumtoxinA-lanm is the first and only peptide-formulated neuromodulator to reduce frown lines, with results lasting longer than conventional neuromodulators, according to the manufacturer.
Researchers analyzed participants in a 3-year extension of the phase 3 CO-STAR trial that evaluated elbasvir and grazoprevir in people consistently taking opioid agonist therapy.
Although some clinicians are hesitant to prescribe long-acting injectables for schizophrenia, new research suggests they re superior to oral antipsychotics in preventing relapse ― and they re safer.